- Director of the institute of cancer theraputics, University of Bradford, United kingdom.
Biography:
El-Khamisy studied pharmacy at Cairo University, obtained a PhD in genomic stability from the University of Sussex UK and received training as a post-doctoral fellow at St Jude Research Hospital in the USA. El-Khamisy was one of the founding members of the School of Pharmacy at Ain Shams University, worked closely with the Nobel Laureate, Prof Ahmed Zewail, to establish the first research centre in Egypt specialised in genomics and genome integrity, which he was the founding director in 2014. In 2018, El-Khamisy co-founded the healthy Lifespan Institute at the University of Sheffield, UK. In 2020, he got a joint appointment to lead the Institute of Cancer Therapeutics at the University of Bradford, directing over 15 research groups that make cancer discoveries and take them to the clinic. In 2021, he was additionally appointed as the Dean of Research, overseeing the schools of Pharmacy and Medical Sciences, Optometry, Chemistry and Biological sciences and the school of Archaeology and Forensic sciences. In 2020, El-Khamisy was appointed to the Board of the Egyptian Genome Project, a Presidential endorsed project unravelling the secrets of Egyptian genes across the lifetime.
El-Khamisy won several prestigious awards including the Wellcome Trust Investigator award and the fellowship of the Lister Institute of Preventative Medicine, UK. El-Khamisy’s work is published in Nature, Cell and Science with over 6000 citations and an H-index of 38. He is an elected Fellow of the Royal Society of Biology, the Royal Society of Chemistry, and his work was recognized by AstraZeneca (UK), the State Award of Excellence in Medical Sciences (Egypt), the Nobel Laurette Ahmed Zewail (Caltech, USA), Shoman Foundation (Jordon) and the Wellcome Trust (UK).
Title of the talk: Harnessing Genomic Stability in Precision Medicine.
Webpage links: